US Cong seeks details of Ranbaxy drug approvals (Business Standard India)
Two United States senators have asked the US Food and Drug Administration (USFDA) to provide details of market approvals given to all medicines sold by India's largest drug-maker Ranbaxy in that country.

FDA bans 30 Ranbaxy drugs; rules out fresh approvals (Express India)
The US Food and Drug Administration, in its biggest action against an Indian pharmaceutical company, has banned over 30 generic drugs manufactured by RLL from entering the US borders. FDA has also ruled out approval to any new Ranbaxy' drugs for now. Ranbaxy, India's largest pharmaceutical company, has recently been bought over by Daiichi Sankyo of Japan, making the combined entity the fifteenth ...